Yunnan Baiyao Group Co., Ltd.

Yunnan Baiyao Group Co., Ltd. is a modern pharmaceutical manufacturing company based in China, listed on the Shenzhen Stock Exchange since 1993. The company focuses on the health sector and adheres to "4P" practices, which include Good Agricultural Practices (GAP), Good Laboratory Practices (GLP), Good Manufacturing Practices (GMP), and Good Supply Practices (GSP). Yunnan Baiyao is known for its commitment to traditional Chinese medicine and has developed a comprehensive business model that encompasses manufacturing, pharmaceutical development, medical distribution, and personal health care products. The company's product portfolio includes over 370 varieties, with a strong emphasis on Yunnan Baiyao series products, which are recognized for their hemostatic, detumescent, and analgesic properties. Additionally, Yunnan Baiyao has established a leading position in the personal care market, particularly with its toothpaste product, which holds the largest market share in China. The company has developed a complete industrial chain for medical health and has implemented advanced technologies to enhance its manufacturing and distribution processes, ensuring a robust and efficient operational framework.

Yunnan Baiyao is a traditional Chinese medicine enterprise with deep historical accumulation. Yunnan Baiyao is a world-famous brand . The brand has been ranked the most valuable brand list of BRANDZ，and Hu Run brand list many times, and its brand awareness, integrity and reputation continue to improve. The company aims to build an Industry 4.0 pharmaceutical company. Through the introduction of new technology and new equipment, the intelligent, automatic and informational integration of industrial manufacturing and commercial logistics is realized. The company established a complete industrial chain of medical health, oriented to market and user needs, through years of research and development, and international cooperation, It has formed high value-added product clusters including medicines, personal healthcare products, functional health foods, medical devices, etc., which are differentiated in quality, value, packaging and marketing. After years of construction and exploration, the company has established a self-owned channel system in the field of pharmaceutical distribution and health product distribution, which covering a wide range, strong terminal control capabilities, and coordinated development of new and old channels. The management of the company has accumulated rich experience in the industry. Based on the company's actual situation, industry development trend and market demand, we made timely and efficient development strategies and guidelines that conform to company's characteristics, and formed a robust, pragmatic and efficient management concept.